Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.
Emory Transplant Center, Emory University School of Medicine, Atlanta, GA 30322, USA.
Cell Rep. 2023 Aug 29;42(8):112993. doi: 10.1016/j.celrep.2023.112993. Epub 2023 Aug 16.
CD8 T cells mediate acute rejection of allografts, which threatens the long-term survival of transplanted organs. Using MHC class I tetramers, we find that allogeneic CD8 T cells are present at an elevated naive precursor frequency relative to other epitopes, only modestly increase in number after grafting, and maintain high T cell receptor diversity throughout the immune response. While antigen-specific effector CD8 T cells poorly express the canonical effector marker KLRG-1, expression of the activated glycoform of CD43 defines potent effectors after transplantation. Activated CD43 effector T cells maintain high expression of the coreceptor induced T cell costimulator (ICOS) in the presence of CTLA-4 immunoglobulin (Ig), and dual CTLA-4 Ig/anti-ICOS treatment prolongs graft survival. These data demonstrate that graft-specific CD8 T cells have a distinct response profile relative to anti-pathogen CD8 T cells and that CD43 and ICOS are critical surface receptors that define potent effector CD8 T cell populations that form after transplantation.
CD8 T 细胞介导同种异体移植物的急性排斥反应,这威胁着移植器官的长期存活。使用 MHC Ⅰ类四聚体,我们发现同种异体 CD8 T 细胞以高于其他表位的幼稚前体频率存在,在移植后数量仅适度增加,并在整个免疫反应中保持高 T 细胞受体多样性。虽然抗原特异性效应 CD8 T 细胞很少表达经典效应标志物 KLRG-1,但 CD43 的激活糖型的表达在移植后定义了有效的效应器。在 CTLA-4 免疫球蛋白 (Ig) 的存在下,激活的 CD43 效应 T 细胞保持高表达共刺激受体诱导的 T 细胞共刺激因子 (ICOS),双重 CTLA-4 Ig/抗 ICOS 治疗可延长移植物存活期。这些数据表明,与抗病原体 CD8 T 细胞相比,移植特异性 CD8 T 细胞具有独特的反应特征,并且 CD43 和 ICOS 是定义移植后形成的有效效应 CD8 T 细胞群体的关键表面受体。